The conversion of adenosine to inosine by RNA editing represents an increasingly important mechanism for generating diversity in neurotransmitter receptor expression. Such RNA modifications have been shown to alter both the ion permeation and electrophysiological properties of ligand-gated ion channels and to modulate the efficacy of receptor G-protein interactions. Recent studies in our laboratory have demonstrated that ADAR2, a double-stranded RNA-specific adenosine deaminase involved in the editing of glutamate and serotonin receptor transcripts, can selectively modify its own pre-mRNA, suggesting a negative autoregulatory mechanism by which ADAR2 can modulate its own expression level to prevent editing at aberrant sites. The long-term objectives of these studies are to define the cellular processes by which such RNA editing events can modulate neurotransmitter receptor expression and function in the central nervous system. To identify the cis-active regulatory sequences necessary for ADAR2 editing, a tissue culture model system will be utilized that exhibits RNA processing patterns analogous to those observed in vivo. Analyses of RNA from cells transfected with a variety of mutant ADAR2 minigene constructs will serve as the primary methodology for these mapping studies. An in vitro RNA editing system, utilizing purified, recombinant ADAR proteins, will also be used as a mapping technique and to further define the ADAR proteins responsible for site-specific modifications of ADAR2 pre-mRNA. The effect of ADAR2 protein levels on the specificity of adenosine modification will be examined using an inducible tissue culture system and an in vitro editing system to test whether over expression of ADAR2 can lead to the modification of known ADAR2 substrates(GluR-Band 5-HT2CR) at aberrant sites competition studiesbetweenADAR2 pre-mRNA and otherADAR2 substrates will be performed to determine if such competition represents a cellular mechanism for maintaining appropriate ADAR2 protein levels. To examine the molecular and phenotypic consequences of ADAR2 misregulation, genetically modified strains of mice will be generated in which ADAR2 levels have been altered by over expression or by selective ablation of ADAR2 auto editing. Multiple, independent mouse lines will be assessed for gross alterations in animal phenotype, changes in the level of ADAR2 expression/activity, alterations in editing patterns for previously identified ADAR2 substrates and increases in mRNA-derived inosine content. It is anticipated that these studies will provide new insights concerning the cellular processes modulatingADAR2 expression as well as the effects that such modulation confer upon the expression of neurotransmitter receptor isoforms.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS033323-08
Application #
6639464
Study Section
Special Emphasis Panel (ZRG1-MDCN-5 (01))
Program Officer
Stewart, Randall
Project Start
1995-06-01
Project End
2006-04-30
Budget Start
2003-05-01
Budget End
2006-04-30
Support Year
8
Fiscal Year
2003
Total Cost
$264,250
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pharmacology
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
O'Neil, Richard T; Emeson, Ronald B (2012) Quantitative analysis of 5HT(2C) receptor RNA editing patterns in psychiatric disorders. Neurobiol Dis 45:8-13
Hood, Jennifer L; Emeson, Ronald B (2012) Editing of neurotransmitter receptor and ion channel RNAs in the nervous system. Curr Top Microbiol Immunol 353:61-90
Stefl, Richard; Oberstrass, Florian C; Hood, Jennifer L et al. (2010) The solution structure of the ADAR2 dsRBM-RNA complex reveals a sequence-specific readout of the minor groove. Cell 143:225-37
Lanfranco, Maria Fe; Seitz, Patricia K; Morabito, Michael V et al. (2009) An innovative real-time PCR method to measure changes in RNA editing of the serotonin 2C receptor (5-HT(2C)R) in brain. J Neurosci Methods 179:247-57
Jacobs, Michelle M; Fogg, Rachel L; Emeson, Ronald B et al. (2009) ADAR1 and ADAR2 expression and editing activity during forebrain development. Dev Neurosci 31:223-37
Rula, Elizabeth Y; Lagrange, Andre H; Jacobs, Michelle M et al. (2008) Developmental modulation of GABA(A) receptor function by RNA editing. J Neurosci 28:6196-201
Singh, Minati; Kesterson, Robert A; Jacobs, Michelle M et al. (2007) Hyperphagia-mediated obesity in transgenic mice misexpressing the RNA-editing enzyme ADAR2. J Biol Chem 282:22448-59
Rula, Elizabeth Y; Emeson, Ronald B (2007) Mouse models to elucidate the functional roles of adenosine-to-inosine editing. Methods Enzymol 424:333-67
Stefl, Richard; Xu, Ming; Skrisovska, Lenka et al. (2006) Structure and specific RNA binding of ADAR2 double-stranded RNA binding motifs. Structure 14:345-55
Feng, Yi; Sansam, Christopher L; Singh, Minati et al. (2006) Altered RNA editing in mice lacking ADAR2 autoregulation. Mol Cell Biol 26:480-8

Showing the most recent 10 out of 13 publications